# 2026-09244: FDA Plans Testing for Medical Device Communication Clarity

2026-09244, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-11, effective Submit written comments (including recommendations) on the collection of information by June 10, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-09244
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-09244
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 25582
- Published: 2026-05-11
- Effective: Submit written comments (including recommendations) on the collection of information by June 10, 2026.
- Comments close: 2026-06-10
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Plans Testing for Medical Device Communication Clarity

## Summary

The FDA is asking for public comments on their plan to keep testing how they communicate about medical devices and radiation products. This helps them make sure their messages reach patients, caregivers, and healthcare pros clearly and effectively. Comments are due by June 10, 2026, and this review won’t cost anyone extra but will improve important health info.

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

- FDA Will Test Device Communication: benefit, low. The FDA’s Center for Devices and Radiological Health will collect information to test and improve messages about medical devices and radiation-emitting products using interviews, focus groups, surveys, and other research methods so messages better reach patients, caregivers, and health professional…
- Participation Time Burden Estimated: cost, low. FDA estimates the studies will involve 9,124 total respondents with an average burden of 16 minutes per respondent (range 5 to 90 minutes) and a total annual respondent burden of 2,391 hours across activities.
- No Monetary Costs To Respondents: benefit, low. FDA states there are no capital costs or operating and maintenance costs associated with this information collection, meaning respondents will not incur those types of expenses from participating.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-09244 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/11/2026-09244/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-09244 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-11/pdf/2026-09244.pdf)

## Related
- [Previous: 2026-09243, Certain Photodynamic Therapy Systems, Components Thereof, and Pharmaceutical Pr…](https://policyrisk.com/federal-register/2026-09243)
- [Next: 2026-09245, World Trade Center Health Program; Petitions 032, 033, and 068-Peripheral Neuro…](https://policyrisk.com/federal-register/2026-09245)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-09244 (as of 2026-06-08).
